Question to the Department of Health and Social Care:

To ask Her Majesty’s Government what discussions they have had with the manufacturers of the Meningitis B vaccine Bexsero on behalf of all health departments within the United Kingdom.

We have had a number of meetings with the manufacturer for supply of the meningococcal B vaccine, Bexsero^® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, and we are continuing to meet.

The Department is conducting these negotiations on behalf of the devolved administrations, as is usual and agreed practice.